메뉴 건너뛰기




Volumn 29, Issue 1, 2011, Pages 58-65

A disproportion of TH1/TH2 cytokines with predominance of TH2, in urothelial carcinoma of bladder

Author keywords

T helper cells; TH1 cytokines; TH1 TH2; TH2 cytokines; Urinogenital cancer; Urothelial carcinoma of bladder

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; CYTOKINE;

EID: 78650679301     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.06.002     Document Type: Article
Times cited : (40)

References (47)
  • 1
    • 0033948443 scopus 로고    scopus 로고
    • Bladder cancer staging
    • Macvicar A.D. Bladder cancer staging. BJU Int 2000, 86(Suppl 1):111-122.
    • (2000) BJU Int , vol.86 , Issue.SUPPL 1 , pp. 111-122
    • Macvicar, A.D.1
  • 2
    • 0034199347 scopus 로고    scopus 로고
    • Bladder Cancer: A review of diagnosis and management
    • Metts M.C., Metts J.C., Milito S.J., et al. Bladder Cancer: A review of diagnosis and management. J Natl Med Assoc 2000, 92:285-294.
    • (2000) J Natl Med Assoc , vol.92 , pp. 285-294
    • Metts, M.C.1    Metts, J.C.2    Milito, S.J.3
  • 3
    • 0026516935 scopus 로고
    • Intravesical therapy, does it affect the natural history of bladder cancer?
    • Lamm D.L., Griffith J.G. Intravesical therapy, does it affect the natural history of bladder cancer?. Sem Urol 1992, 10:39-44.
    • (1992) Sem Urol , vol.10 , pp. 39-44
    • Lamm, D.L.1    Griffith, J.G.2
  • 4
    • 0033016139 scopus 로고    scopus 로고
    • The long term outcome in patients with superficial urothelial carcinoma of the bladder: A single-institutional experience
    • Hukaas S., Daehlin L., Maartman-Moe H., et al. The long term outcome in patients with superficial urothelial carcinoma of the bladder: A single-institutional experience. BJU Int 1999, 83:957-963.
    • (1999) BJU Int , vol.83 , pp. 957-963
    • Hukaas, S.1    Daehlin, L.2    Maartman-Moe, H.3
  • 5
    • 0015323091 scopus 로고
    • Immunological unreactivity in bladder cancer patients
    • Olsson C.A., Rao C.N., Menzoian J.O., et al. Immunological unreactivity in bladder cancer patients. J Urol 1972, 107:607-609.
    • (1972) J Urol , vol.107 , pp. 607-609
    • Olsson, C.A.1    Rao, C.N.2    Menzoian, J.O.3
  • 6
    • 0347302952 scopus 로고    scopus 로고
    • Cytokines in cancer pathogenesis and cancer therapy
    • Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nature Rev 2004, 4:12-22.
    • (2004) Nature Rev , vol.4 , pp. 12-22
    • Dranoff, G.1
  • 7
    • 47649093316 scopus 로고    scopus 로고
    • Inflammation: Its role and interplay in the development of cancer, with special focus on gynecological malignancies
    • Goswami B., Rajappa M., Sharma M., et al. Inflammation: Its role and interplay in the development of cancer, with special focus on gynecological malignancies. Int J Gynecol Cancer 2008, 18:591-599.
    • (2008) Int J Gynecol Cancer , vol.18 , pp. 591-599
    • Goswami, B.1    Rajappa, M.2    Sharma, M.3
  • 8
    • 0025903403 scopus 로고
    • Evaluation of a test system for measuring cytokine production in human whole blood cell cultures
    • Elssser-Belie U., von-Kleist S., Gallati H. Evaluation of a test system for measuring cytokine production in human whole blood cell cultures. J Immunol Methods 1991, 139:191-195.
    • (1991) J Immunol Methods , vol.139 , pp. 191-195
    • Elssser-Belie, U.1    von-Kleist, S.2    Gallati, H.3
  • 9
    • 0029859871 scopus 로고    scopus 로고
    • Type 1 and type 2 cytokines dysregulation in human infectious, neoplastic, and inflammatory diseases
    • Lucey D.R., Clerece M., Shearer G.M. Type 1 and type 2 cytokines dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996, 9:533-562.
    • (1996) Clin Microbiol Rev , vol.9 , pp. 533-562
    • Lucey, D.R.1    Clerece, M.2    Shearer, G.M.3
  • 10
    • 41149097574 scopus 로고    scopus 로고
    • Adoptive cell transfer: A clinical path to effective cancer immunotherapy
    • Rosenberg S.A., Restifo N.P., Yang J.C., et al. Adoptive cell transfer: A clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008, 8:299-308.
    • (2008) Nat Rev Cancer , vol.8 , pp. 299-308
    • Rosenberg, S.A.1    Restifo, N.P.2    Yang, J.C.3
  • 11
    • 0035134439 scopus 로고    scopus 로고
    • Type 1/type 2 immunity in infectious diseases
    • Spellberg B., Edwards J.E. Type 1/type 2 immunity in infectious diseases. Clin Infect Dis 2001, 32:76-102.
    • (2001) Clin Infect Dis , vol.32 , pp. 76-102
    • Spellberg, B.1    Edwards, J.E.2
  • 12
    • 85066230615 scopus 로고
    • The Th1/Th2 hypothesis of HIV infections: New Insights
    • Clerece M., Shearer G.M. The Th1/Th2 hypothesis of HIV infections: New Insights. Immunol Today 1994, 15:245-250.
    • (1994) Immunol Today , vol.15 , pp. 245-250
    • Clerece, M.1    Shearer, G.M.2
  • 13
    • 0036158859 scopus 로고    scopus 로고
    • Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production
    • Morikawa K., Zhang J., Nonaka M., et al. Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production. Int J Antimicrob Agents 2002, 19:53-59.
    • (2002) Int J Antimicrob Agents , vol.19 , pp. 53-59
    • Morikawa, K.1    Zhang, J.2    Nonaka, M.3
  • 14
    • 0029124129 scopus 로고
    • Human non-small cell lung cancer cells express a type 2 cytokine pattern
    • Huang M., Wang J., Lee P., et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 1995, 55:3847-3853.
    • (1995) Cancer Res , vol.55 , pp. 3847-3853
    • Huang, M.1    Wang, J.2    Lee, P.3
  • 15
    • 33947720523 scopus 로고    scopus 로고
    • Development in motion: Helper T cells at work
    • Reiner S.L. Development in motion: Helper T cells at work. Cell 2007, 129:33-36.
    • (2007) Cell , vol.129 , pp. 33-36
    • Reiner, S.L.1
  • 16
    • 0036721629 scopus 로고    scopus 로고
    • Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
    • Liyanage U.K., Moore T.T., Joo H., et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002, 169:2756-2761.
    • (2002) J Immunol , vol.169 , pp. 2756-2761
    • Liyanage, U.K.1    Moore, T.T.2    Joo, H.3
  • 18
    • 0023232366 scopus 로고
    • Two types of mouse T helper cell clone implication for immune regulation
    • Mosmann T.R., Coffman R.L. Two types of mouse T helper cell clone implication for immune regulation. Immunol Today 1987, 8:223-226.
    • (1987) Immunol Today , vol.8 , pp. 223-226
    • Mosmann, T.R.1    Coffman, R.L.2
  • 19
    • 34447333699 scopus 로고    scopus 로고
    • Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix
    • Sharma A., Rajappa M., Saxena A., et al. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. Int J Gynecol Cancer 2007, 17:879-885.
    • (2007) Int J Gynecol Cancer , vol.17 , pp. 879-885
    • Sharma, A.1    Rajappa, M.2    Saxena, A.3
  • 20
    • 34347250876 scopus 로고    scopus 로고
    • Mechanism and therapeutic reversal of immune suppression in cancer
    • Herber D.L., Nagaraj S., Djeu J.Y., et al. Mechanism and therapeutic reversal of immune suppression in cancer. Cancer Res 2007, 67:5067-5069.
    • (2007) Cancer Res , vol.67 , pp. 5067-5069
    • Herber, D.L.1    Nagaraj, S.2    Djeu, J.Y.3
  • 21
    • 31344453943 scopus 로고    scopus 로고
    • Immune suppression in cancer: Effects on immune cells, mechanisms, and future therapeutic intervention
    • Whiteside T.L. Immune suppression in cancer: Effects on immune cells, mechanisms, and future therapeutic intervention. Semin Cancer Biol 2006, 16:80-88.
    • (2006) Semin Cancer Biol , vol.16 , pp. 80-88
    • Whiteside, T.L.1
  • 22
    • 17644394616 scopus 로고    scopus 로고
    • Smoldering and polarized inflammation in the initiation and promotion of malignant disease
    • Balkwill F., Charles K.A., Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005, 7:211-217.
    • (2005) Cancer Cell , vol.7 , pp. 211-217
    • Balkwill, F.1    Charles, K.A.2    Mantovani, A.3
  • 23
    • 31344466956 scopus 로고    scopus 로고
    • Chronic inflammation, immunosuppression and cancer: New insights and outlook
    • Baniyash M. Chronic inflammation, immunosuppression and cancer: New insights and outlook. Semin Cancer Biol 2006, 16:80-88.
    • (2006) Semin Cancer Biol , vol.16 , pp. 80-88
    • Baniyash, M.1
  • 24
    • 33644588729 scopus 로고    scopus 로고
    • Flow cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of superficial transitional cell carcinoma of bladder
    • Agarwal A., Verma S., Burra U., et al. Flow cytometric analysis of Th1 and Th2 cytokines in PBMCs as a parameter of immunological dysfunction in patients of superficial transitional cell carcinoma of bladder. Cancer Immunol Immunother 2006, 55:734-743.
    • (2006) Cancer Immunol Immunother , vol.55 , pp. 734-743
    • Agarwal, A.1    Verma, S.2    Burra, U.3
  • 26
    • 0036176551 scopus 로고    scopus 로고
    • Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery
    • Galizia G., Orditura M., Romano C., et al. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin Immunol 2002, 102:169-178.
    • (2002) Clin Immunol , vol.102 , pp. 169-178
    • Galizia, G.1    Orditura, M.2    Romano, C.3
  • 27
    • 32944479702 scopus 로고    scopus 로고
    • Cytokine and immuno-gene therapy for solid tumors
    • Li C., Huang Q., Kung H. Cytokine and immuno-gene therapy for solid tumors. Cell Mol Immunol 2005, 2:81-91.
    • (2005) Cell Mol Immunol , vol.2 , pp. 81-91
    • Li, C.1    Huang, Q.2    Kung, H.3
  • 28
    • 0025923025 scopus 로고
    • Human Thl and Th2 subsets: Doubt no more
    • Romagnani S. Human Thl and Th2 subsets: Doubt no more. Immunol Today 1991, 72:256-257.
    • (1991) Immunol Today , vol.72 , pp. 256-257
    • Romagnani, S.1
  • 29
    • 0038712135 scopus 로고    scopus 로고
    • Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma
    • Agarwal A., Rani M., Saha G.K., et al. Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma. Immunol Invest 2003, 32:17-30.
    • (2003) Immunol Invest , vol.32 , pp. 17-30
    • Agarwal, A.1    Rani, M.2    Saha, G.K.3
  • 30
    • 26244467124 scopus 로고    scopus 로고
    • A shift to peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions
    • Bais A.G., Beckmann I., Lindemans J., et al. A shift to peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol 2005, 58:1096-1100.
    • (2005) J Clin Pathol , vol.58 , pp. 1096-1100
    • Bais, A.G.1    Beckmann, I.2    Lindemans, J.3
  • 31
    • 0028127139 scopus 로고
    • Cytokine mediated antitumor effects of bacillus Calmette-Guerin on tumor cells in vitro
    • Kurisu H., Matsuyama H., Ohmoto Y., et al. Cytokine mediated antitumor effects of bacillus Calmette-Guerin on tumor cells in vitro. Cancer Immunol Immunother 1994, 39:249-253.
    • (1994) Cancer Immunol Immunother , vol.39 , pp. 249-253
    • Kurisu, H.1    Matsuyama, H.2    Ohmoto, Y.3
  • 32
    • 0028179006 scopus 로고
    • Lymphocyte responses and cytokines
    • Paul W.E., Seder R.A. Lymphocyte responses and cytokines. Cell 1994, 76:241-251.
    • (1994) Cell , vol.76 , pp. 241-251
    • Paul, W.E.1    Seder, R.A.2
  • 33
    • 0031905978 scopus 로고    scopus 로고
    • Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: Statistically weighted syndrome analysis
    • Jackson A.M., Ivshina A.V., Senko O., et al. Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: Statistically weighted syndrome analysis. J Urol 1998, 159:1054-1063.
    • (1998) J Urol , vol.159 , pp. 1054-1063
    • Jackson, A.M.1    Ivshina, A.V.2    Senko, O.3
  • 34
    • 0024240262 scopus 로고
    • Interleukin-2 in cancer therapy
    • Parkinson D.R. Interleukin-2 in cancer therapy. Sem in Oncol 1988, 15(Suppl 6):10-26.
    • (1988) Sem in Oncol , vol.15 , Issue.SUPPL 6 , pp. 10-26
    • Parkinson, D.R.1
  • 35
    • 0029885357 scopus 로고    scopus 로고
    • Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression
    • Kaempfer R., Gerez L., Farbstein H., et al. Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression. J Clin Oncol 1996, 14:1778-1786.
    • (1996) J Clin Oncol , vol.14 , pp. 1778-1786
    • Kaempfer, R.1    Gerez, L.2    Farbstein, H.3
  • 36
    • 0041917266 scopus 로고    scopus 로고
    • Th1/Th2 Balance: The hypothesis, its limitations, and implications for health and disease
    • Kidd P. Th1/Th2 Balance: The hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003, 8:223-246.
    • (2003) Altern Med Rev , vol.8 , pp. 223-246
    • Kidd, P.1
  • 37
    • 0034145323 scopus 로고    scopus 로고
    • Serum interleukin-10 is an independent prognostic factor in advanced solid tumors
    • De Vita F., Orditura M., Galizia G., et al. Serum interleukin-10 is an independent prognostic factor in advanced solid tumors. Oncol Rep 2000, 7:357-361.
    • (2000) Oncol Rep , vol.7 , pp. 357-361
    • De Vita, F.1    Orditura, M.2    Galizia, G.3
  • 38
    • 33746083294 scopus 로고    scopus 로고
    • Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma
    • Lech-Maranda E., Bienvenu J., Michallet A.S., et al. Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma. Eur Cytokine Network 2006, 17:60-66.
    • (2006) Eur Cytokine Network , vol.17 , pp. 60-66
    • Lech-Maranda, E.1    Bienvenu, J.2    Michallet, A.S.3
  • 39
    • 47249134619 scopus 로고    scopus 로고
    • Strategies for use of IL-10 or its antagonists in human disease
    • O'Garra A., Barrat F.J., Castro A.G., et al. Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 2008, 223:114-131.
    • (2008) Immunol Rev , vol.223 , pp. 114-131
    • O'Garra, A.1    Barrat, F.J.2    Castro, A.G.3
  • 40
    • 0031774084 scopus 로고    scopus 로고
    • Impaired production of Th1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients
    • Sato M., Goto S., Kaneko R., et al. Impaired production of Th1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients. Anticancer Res 1998, 18:3951-3955.
    • (1998) Anticancer Res , vol.18 , pp. 3951-3955
    • Sato, M.1    Goto, S.2    Kaneko, R.3
  • 41
    • 0033840037 scopus 로고    scopus 로고
    • Analysis of type T1 and T2 cytokines in patients with prostate cancer
    • Filella X., Alcover J., Zarco M.A., et al. Analysis of type T1 and T2 cytokines in patients with prostate cancer. Prostate 2000, 44:271-274.
    • (2000) Prostate , vol.44 , pp. 271-274
    • Filella, X.1    Alcover, J.2    Zarco, M.A.3
  • 42
    • 0032539920 scopus 로고    scopus 로고
    • Glutathione levels in antigen presenting cells modulate Th1 versus Th2 response patterns
    • Peterson J.D., Herzenberg L.A., Vasquez K., et al. Glutathione levels in antigen presenting cells modulate Th1 versus Th2 response patterns. Proc Nat Acad Sci USA 1998, 95:3071-3076.
    • (1998) Proc Nat Acad Sci USA , vol.95 , pp. 3071-3076
    • Peterson, J.D.1    Herzenberg, L.A.2    Vasquez, K.3
  • 43
    • 0036165578 scopus 로고    scopus 로고
    • The polarization of Th1/Th2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production
    • Murata Y., Shimamura T., Hamuro J. The polarization of Th1/Th2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production. Int Immunol 2002, 14:201-212.
    • (2002) Int Immunol , vol.14 , pp. 201-212
    • Murata, Y.1    Shimamura, T.2    Hamuro, J.3
  • 44
    • 0036128321 scopus 로고    scopus 로고
    • The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content
    • Murata Y., Shimamura T., Tagami T., et al. The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol 2002, 2:673-689.
    • (2002) Int Immunopharmacol , vol.2 , pp. 673-689
    • Murata, Y.1    Shimamura, T.2    Tagami, T.3
  • 45
    • 69949122932 scopus 로고    scopus 로고
    • Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma
    • [Epub ahead of print]
    • Badjatia N., Satyam A., Singh P., et al. Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol 2009 Jan 24, [Epub ahead of print].
    • (2009) Urol Oncol
    • Badjatia, N.1    Satyam, A.2    Singh, P.3
  • 46
    • 34250707858 scopus 로고    scopus 로고
    • Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation
    • Sharma A., Rajjapa M., Saxena A., et al. Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation. Br J Biomed Sci 2007, 64:23-27.
    • (2007) Br J Biomed Sci , vol.64 , pp. 23-27
    • Sharma, A.1    Rajjapa, M.2    Saxena, A.3
  • 47
    • 0034046276 scopus 로고    scopus 로고
    • Cytokine therapy for cancer
    • Tagawa M. Cytokine therapy for cancer. Curr Pharm Des 2000, 6:681-699.
    • (2000) Curr Pharm Des , vol.6 , pp. 681-699
    • Tagawa, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.